A share price of Charles River Laboratories International Inc [CRL] is currently trading at $190.14, up 2.16%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The CRL shares have gain 2.34% over the last week, with a monthly amount drifted -3.51%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Charles River Laboratories International Inc [NYSE: CRL] stock has seen the most recent analyst activity on November 18, 2024, when CLSA downgraded its rating to a Underperform but kept the price target unchanged to $164 for it. Previously, CLSA upgraded its rating to Hold on November 07, 2024, and kept the price target unchanged to $205. On October 23, 2024, CLSA initiated with a Underperform rating and assigned a price target of $167 on the stock. Redburn Atlantic started tracking the stock assigning a Sell rating. Evercore ISI downgraded its rating to a In-line and reduced its price target to $190 on October 07, 2024. BofA Securities downgraded its rating to Neutral for this stock on October 02, 2024, and downed its price target to $215. In a note dated October 01, 2024, Citigroup downgraded an Sell rating on this stock and revised its target price from $215 to $175.
Charles River Laboratories International Inc experienced fluctuations in its stock price throughout the past year between $176.48 and $275.00. Currently, Wall Street analysts expect the stock to reach $201.5 within the next 12 months. Charles River Laboratories International Inc [NYSE: CRL] shares were valued at $190.14 at the most recent close of the market. An investor can expect a potential return of 5.97% based on the average CRL price forecast.
Analyzing the CRL fundamentals
Trailing Twelve Months sales for Charles River Laboratories International Inc [NYSE:CRL] were 4.06B which represents -1.64% decline. Gross Profit Margin for this corporation currently stands at 0.34% with Operating Profit Margin at 0.14%, Pretax Profit Margin comes in at 0.13%, and Net Profit Margin reading is 0.1%. To continue investigating profitability, this company’s Return on Assets is posted at 0.05, Equity is 0.11 and Total Capital is 0.08. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.61.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 186.20 points at the first support level, and at 182.26 for the second support level. However, for the 1st resistance point, the stock is sitting at 192.38, and for the 2nd resistance point, it is at 194.62.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Charles River Laboratories International Inc [NYSE:CRL] is 1.48. Also, the Quick Ratio is 1.14, while the Cash Ratio stands at 0.21. Considering the valuation of this stock, the price to sales ratio is 2.39, the price to book ratio is 2.57 and price to earnings (TTM) ratio is 23.48.
Transactions by insiders
Recent insider trading involved WALLMAN RICHARD F, Director, that happened on Nov 07 ’24 when 6621.0 shares were sold. Director, WALLMAN RICHARD F completed a deal on Nov 07 ’24 to sell 1000.0 shares. Meanwhile, Director WALLMAN RICHARD F bought 12161.0 shares on Nov 07 ’24.
